Information  X 
Enter a valid email address

Indivior Plc Ord USD0.10 (INDV)

Related News

15-Oct-2019 08:02 AM

Indivior upgrades profit outlook on stronger sales of opioid addiction drug

Drug company Indivior upgraded its full-year profit outlook as sales of its opioid addiction treatment fared better than expected despite competition from generics. Full-year revenue was now expected to be in the range of $750m to $790m, up from a rang
11-Jul-2019 08:26 AM

Indivior raises guidance as opioid addiction treatment fares better than expected in H1

Drugmaker Indivior raised its earnings guidance on a stronger-than-expected first half, during which its opioid-addiction treatment loss less market share than expected following the launch of copycat drugs from rivals. Indivior said it now expected f
18-Feb-2019 10:20 AM

Broker Forecast - Jefferies International issues a broker note on Indivior Plc

Jefferies International today downgrades its investment rating on Indivior Plc (LON:INDV) to hold (from buy) and cut its price target to 114p (from 118p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk.
14-Feb-2019 09:09 AM

Indivior cost cuts help boost profits; warns of 'imminent' risk from copycat products

Indivior reported Thursday a rise in profits as cost cuts helped bolster performance even as revenues slipped amid a series of market challenges. The company warned, however, of an 'imminent' risk to performance from the launch of generic rival
12-Dec-2018 10:20 AM

Broker Forecast - RBC Capital Markets issues a broker note on Indivior Plc

RBC Capital Markets today downgrades its investment rating on Indivior Plc (LON:INDV) to sector performer (from outperform). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
27-Nov-2018 08:12 AM

Indivior to provide update on plans, strategy on Dec. 18

Indivior said Tuesday it would discuss its strategy and contingency plans in a December conference call after a US court allowed rival Dr. Reddy's Laboratories to sell a generic version of the company's opioid addiction treatment. The company s
21-Nov-2018 09:50 AM

Broker Forecast - RBC Capital Markets issues a broker note on Indivior Plc

RBC Capital Markets today downgrades its investment rating on Indivior Plc (LON:INDV) to outperform (from outperform) and cut its price target to 130p (from 350p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazi
11-Oct-2018 08:00 AM

Broker Forecast - Jefferies International issues a broker note on Indivior Plc

Jefferies International today reaffirms its buy investment rating on Indivior Plc (LON:INDV) and cut its price target to 245p (from 250p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
27-Jul-2018 09:10 AM

Broker Forecast - Numis issues a broker note on Indivior Plc

Numis today upgrades its investment rating on Indivior Plc (LON:INDV) to buy (from add). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
26-Jul-2018 01:10 PM

Broker Forecast - Citigroup issues a broker note on Indivior Plc

Citigroup today reaffirms its neutral investment rating on Indivior Plc (LON:INDV) and cut its price target to 350p (from 365p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
25-Jul-2018 12:40 PM

Broker Forecast - Numis issues a broker note on Indivior Plc

Numis today upgrades its investment rating on Indivior Plc (LON:INDV) to add (from hold). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
25-Jul-2018 08:10 AM

Indivior profits slip in H1, warns of 'materially higher' impact from copycat drug

Indivior Wednesday warned that the impact from the launch of a generic version of its opioid addiction treatment 'could be materially higher' in 2018 after first-half net profit slipped 6%. The company said the adverse impact on 2018 net revenu
17-Jul-2018 08:40 AM

Broker Forecast - Citigroup issues a broker note on Indivior Plc

Citigroup today reaffirms its neutral investment rating on Indivior Plc (LON:INDV) and cut its price target to 365p (from 500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
16-Jul-2018 08:40 AM

Broker Forecast - Jefferies International issues a broker note on Indivior Plc

Jefferies International today reaffirms its buy investment rating on Indivior Plc (LON:INDV) and cut its price target to 545p (from 630p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Jul-2018 09:50 AM

Broker Forecast - Numis issues a broker note on Indivior Plc

Numis today downgrades its investment rating on Indivior Plc (LON:INDV) to hold (from buy). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Jul-2018 07:54 AM

Indivior warns on profits as competitors launch generic opioid addiction treatment

Indivior warned Wednesday that net revenue and net income would fall short of previous guidance, as the launch of generic versions of its opioid addiction treatment in the United States would weigh on performance. The profit warning came after Dr.Reddy
19-Jun-2018 09:20 AM

Broker Forecast - Morgan Stanley issues a broker note on Indivior Plc

Morgan Stanley today reaffirms its equal weight investment rating on Indivior Plc (LON:INDV) and cut its price target to 398p (from 455p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-Jun-2018 11:10 AM

Broker Forecast - RBC Capital Markets issues a broker note on Indivior Plc

RBC Capital Markets today reaffirms its outperform investment rating on Indivior Plc (LON:INDV) and raised its price target to 550p (from 540p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-May-2018 08:50 AM

Broker Forecast - Citigroup issues a broker note on Indivior Plc

Citigroup today downgrades its investment rating on Indivior Plc (LON:INDV) to neutral (from buy) and raised its price target to 500p (from 490p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
08-May-2018 08:20 AM

Broker Forecast - Jefferies International issues a broker note on Indivior Plc

Jefferies International today reaffirms its buy investment rating on Indivior Plc (LON:INDV) and raised its price target to 630p (from 610p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-May-2018 08:48 AM

Indivior profit falls as Suboxone cedes market share

Indivior pre-tax profit fell in the first quarter of the year as its Suboxone Film treatment lost market share amid increased competition from lower priced generic tablet options. Pre-tax profit fell 5% to $111m in the first quarter from $117m the same p
09-Apr-2018 08:00 AM

Broker Forecast - Jefferies International issues a broker note on Indivior Plc

Jefferies International today reaffirms its buy investment rating on Indivior Plc (LON:INDV) and raised its price target to 610p (from 500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
03-Apr-2018 08:10 AM

Broker Forecast - Morgan Stanley issues a broker note on Indivior Plc

Morgan Stanley today reaffirms its equal weight investment rating on Indivior Plc (LON:INDV) and raised its price target to 455p (from 450p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
23-Mar-2018 12:20 PM

Broker Forecast - Numis issues a broker note on Indivior Plc

Numis today reaffirms its buy investment rating on Indivior Plc (LON:INDV) and set its price target at 600p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-Feb-2018 07:53 AM

Indivior net income, revenue grow in 2017

Indivior reported net income of $58m in 2017, up 66% from a year ago at actual exchange rates and 57% constant currencies, amid an increase in expenses as provisions for investigative and antitrust litigation matters rose to $438m. Net revenue rose to $
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t